PYC 4.76% 10.0¢ pyc therapeutics limited

Ann: Visual Improvement in Multiple RP11 Patients, page-5

  1. 89 Posts.
    lightbulb Created with Sketch. 70
    Just my opinion but I think it’s pretty clear this treatment is going to work and it’s just a matter of ticking boxes for approval now. This awesome level of treatment response is pretty much unheard of. It has big implications for our other drugs because we now have proof of concept. Obviously they also have to be proven and go through the trials, however, if you take the kidney example. It has been proven in human tissue and primate models. The way PYC works these drug’s up leaves a very narrow window for failure. I.e. a high probability of success. Feels like we are now just going through the motions for inevitable success. Maybe I’m too optimistic apologies if so.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
-0.005(4.76%)
Mkt cap ! $466.6M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $164.3K 1.580M

Buyers (Bids)

No. Vol. Price($)
13 764309 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 304706 7
View Market Depth
Last trade - 15.44pm 13/08/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.